Refractory Urge Incontinence and Botox Injections
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Linda Brubaker, MD
Loyola University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- Uscd Medical Center
La Jolla, California, United States
- Kaiser Permanente
San Diego, California, United States
- Loyola University
Maywood, Illinois, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Ut Southwestern
Dallas, Texas, United States
- Univeristy of Utah
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2006
- Primary completion
- 31 Dec 2007
- Completion
- 31 Dec 2007
- Last update posted
- 11 Jan 2011
- Registered enrollment
- 87
- Registry id
- NCT00373789
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.